Christophe De Romeuf

Les Ulis, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies.

The Dual Targeting of FcRn and FcγRs via Monomeric Fc Fragments Results in Strong Inhibition of IgG-Dependent Autoimmune Pathologies.

Journal: Frontiers in immunology
Published: June 21, 2021

Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.

Hyper-Enriched Anti-RSV Immunoglobulins Nasally Administered: A Promising Approach for Respiratory Syncytial Virus Prophylaxis.

Journal: Frontiers in immunology
Published: March 22, 2021

Transgenic goats producing an improved version of cetuximab in milk.

Transgenic goats producing an improved version of cetuximab in milk.

Journal: FASEB bioAdvances
Published: July 22, 2020

EMABling®, a technology boosting the effector function of monoclonal antibodies: history and clinical applications twenty years after the discovery

EMABling®, a technology boosting the effector function of monoclonal antibodies: history and clinical applications twenty years after the discovery

Journal: Medecine sciences : M/S
Published: January 07, 2020

Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies.

Fc Sialylation Prolongs Serum Half-Life of Therapeutic Antibodies.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 27, 2018

Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.

Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation pattern.

Journal: mAbs
Published: March 20, 2018

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.

Journal: Oncotarget
Published: November 15, 2016

The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.

The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenström macroglobulinemia.

Journal: Haematologica
Published: January 02, 2015

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions.

Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions.

Journal: Frontiers in immunology
Published: September 09, 2014

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.

Journal: mAbs
Published: February 05, 2014

Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion.

Antibody-dependent cellular cytotoxicity of the optimized anti-CD20 monoclonal antibody ublituximab on chronic lymphocytic leukemia cells with the 17p deletion.

Journal: Leukemia
Published: August 21, 2013

Effect of zinc on human IgG1 and its FcγR interactions.

Effect of zinc on human IgG1 and its FcγR interactions.

Journal: Immunology letters
Published: May 04, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026